美沙酮在成人心脏手术中的应用:系统综述与叙述性合成
复合数据显示单次术中给予美沙酮可减少术后疼痛及阿片类药物消耗,且不增加QTc延长或呼吸抑制风险。0.1-0.3 mg/kg为文献报道剂量,≥0.2 mg/kg镇痛效果更一致,但剂量反应关系也提示谵妄等副作用增加。体外循环显著影响美沙酮血药浓度,需考虑给药时机与剂量。
要点
- 单次术中美沙酮可减少心脏术后疼痛及阿片消耗,不增加QTc延长或呼吸抑制风险。
- 0.1 mg/kg镇痛效果不确切,≥0.2 mg/kg可 consistently 降低术后疼痛评分及阿片消耗。
- 体外循环显著影响美沙酮血药浓度,确定剂量与给药时机时必须考虑。
核心结论
- 单次术中给予美沙酮可减少成人心脏手术后疼痛及阿片类药物消耗,且未增加QTc延长或呼吸抑制风险。
- 证据确定性低,主要因最佳剂量策略、体外循环相关给药时机及长期安全性数据有限。
研究设计与样本
- 对纳入研究进行偏倚风险和质量评估,并以叙述性形式提取和呈现数据。
主要发现
- 研究质量中等至高等,但证据确定性低。
- 复合数据显示单次术中给予美沙酮减少术后疼痛及阿片消耗,不增加QTc延长或呼吸抑制风险。
- 文献报道剂量为0.1-0.3 mg/kg;0.1 mg/kg镇痛效果不明确,≥0.2 mg/kg较短效静脉阿片类药物 consistently 降低术后疼痛评分及阿片消耗。
- 存在剂量反应关系:美沙酮镇痛获益与谵妄等副作用均随剂量增加。
- 体外循环显著影响美沙酮血药浓度,确定最佳剂量和给药时机时必须考虑。
关键数值与推荐
- 文献报道剂量范围为0.1-0.3 mg/kg。
- 0.1 mg/kg镇痛效果不明确;≥0.2 mg/kg consistently 降低术后疼痛评分及阿片消耗。
- 单次术中给予美沙酮未增加QTc延长或呼吸抑制风险。
临床怎么用
- 成人心脏手术中可考虑单次术中给予美沙酮作为多模式镇痛的一部分,以减少术后疼痛及阿片消耗。
- 剂量选择需权衡镇痛获益与谵妄等副作用,≥0.2 mg/kg镇痛效果更一致但副作用风险增加。
- 体外循环显著影响美沙酮血药浓度,给药时机与剂量需结合体外循环考虑。
- 近期观察性研究提示美沙酮可用于心脏手术加速康复多模式方案。
局限性
- 证据确定性低,因最佳剂量策略、体外循环相关给药时机及长期安全性数据有限。
- 需要更多试验来优化美沙酮在该人群中的使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Methadone is a long-acting opioid with multifaceted analgesic properties that is under increasing investigation as an intraoperative analgesic in cardiac surgery. A systematic search of United States National Library of Medicine Database (MEDLINE) and Excerpta Medica Database (EMBASE) databases identified publications investigating the use of intraoperative methadone in adult cardiac surgical patients. The risk of bias and quality of evidence of these studies were assessed, and data from these reports were extracted and presented in a narrative format. Sixteen eligible publications were included. Although the quality of the studies was moderate to high, the certainty of the evidence is low due to the limited available data regarding optimal dosing strategies, timing of administration in relation to cardiopulmonary bypass, and long-term safety outcomes. The composite data suggest that a single dose of intraoperative methadone results in less postoperative pain and opioid consumption postoperatively without any increased risk for QTc prolongation or respiratory depression. Doses of 0.1 to 0.3 mg/kg are reported in the cardiac surgery literature; however, there is evidence of a dose-response relationship with methadone's analgesic benefits and increased deliriogenic side effects. Studies using 0.1 mg/kg reveal equivocal analgesia, whereas the studies administering ≥0.2 mg/kg consistently report lower postoperative pain scores and opioid consumption compared to short-acting intravenous (IV) opioids. Crucially, the use of cardiopulmonary bypass significantly impacts methadone's plasma concentrations and must be considered when determining the optimal dose and timing of administration. Further, recent observational studies offer valuable insight into methadone's role in multimodal enhanced recovery after cardiac surgery protocols. Additional trials are needed to refine methadone usage in this population.
引用
- Kumar N, Bardia A, Hussain N, et al. The Use of Methadone in Adult Cardiac Surgery: A Systematic Review With Narrative Synthesis. Anesth Analg. 2026. PMID: 42085333. doi:10.1213/ANE.0000000000008074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。